Resources from the same session
199O - A phase II study investigating neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive bladder cancer: Final analysis
Presenter: Bernadett Szabados
Session: Proffered paper session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
200O - Pembrolizumab plus axitinib (pembro + axi) vs sunitinib in metastatic renal cell carcinoma (mRCC) outcomes of the KEYNOTE-426 study in patients from eastern Asia
Presenter: Chihiro Kondoh
Session: Proffered paper session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
217O - Pembrolizumab (pembro) combination therapies in patients with metastatic castration-resistant prostate cancer (mCRPC): Cohorts A-C of the phase Ib/II KEYNOTE-365 study
Presenter: Anthony M. Joshua
Session: Proffered paper session on Genitourinary tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant abstracts 199O, 200O and 217O
Presenter: Yuji Miura
Session: Proffered paper session on Genitourinary tumours
Resources:
Slides
Webcast